These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 7624930)

  • 1. Possible interaction between acyclovir and antiepileptic treatment.
    Parmeggiani A; Riva R; Posar A; Rossi PG
    Ther Drug Monit; 1995 Jun; 17(3):312-5. PubMed ID: 7624930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling of the pharmacodynamic interaction between phenytoin and sodium valproate.
    Della Paschoa OE; Voskuyl RA; Danhof M
    Br J Pharmacol; 1998 Dec; 125(7):1610-6. PubMed ID: 9884091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of therapeutic drug monitoring of antiepileptic drugs.
    Irshaid YM; Hamdi AA; Al Homrany M
    Int J Clin Pharmacol Ther; 2003 Mar; 41(3):126-31. PubMed ID: 12665161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between valproic acid and acyclovir after intravenous and oral administration in a rabbit model.
    van Jaarsveld MF; Walubo A; du Plessis JB
    Basic Clin Pharmacol Toxicol; 2007 Dec; 101(6):434-40. PubMed ID: 18028106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic interaction between phenytoin and sodium valproate changes seizure thresholds and pattern.
    Della Paschoa OE; Kruk MR; Hamstra R; Voskuyl RA; Danhof M
    Br J Pharmacol; 1998 Nov; 125(5):997-1004. PubMed ID: 9846637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent interaction between phenytoin and valproic acid.
    Riva R; Albani F; Contin M; Perucca E; Ambrosetto G; Gobbi G; Santucci M; Procaccianti G; Baruzzi A
    Neurology; 1985 Apr; 35(4):510-5. PubMed ID: 3920548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring of antiepileptic drugs.
    Shakya G; Malla S; Shakya KN; Shrestha R
    JNMA J Nepal Med Assoc; 2008; 47(171):94-7. PubMed ID: 19079370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of capecitabine therapy on the blood levels of antiepileptic drugs - report of two cases].
    Tanaka H; Jotoku H; Takasaki M; Ibayashi Y; Watanabe K; Takahashi M
    Gan To Kagaku Ryoho; 2014 Apr; 41(4):527-30. PubMed ID: 24743375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis.
    Churchwell MD; Pasko DA; Smoyer WE; Mueller BA
    Nephrol Dial Transplant; 2009 Jan; 24(1):231-8. PubMed ID: 18723569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of old age and enzyme inducing comedication on the pharmacokinetics of valproic acid at steady-state: A case-matched evaluation based on therapeutic drug monitoring data.
    Fattore C; Messina S; Battino D; Croci D; Mamoli D; Perucca E
    Epilepsy Res; 2006 Aug; 70(2-3):153-60. PubMed ID: 16730950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin--valproic acid interaction in rhesus monkey.
    Koch KM; Ludwick BT; Levy RH
    Epilepsia; 1981 Feb; 22(1):19-25. PubMed ID: 6781887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diminished antiepileptic drug serum levels during acyclovir treatment].
    Iglesias Iglesias AA; Ortega García MP; Guevara Serrano J
    Med Clin (Barc); 2005 Mar; 124(9):355-6. PubMed ID: 15760605
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oligospermia improved by switching an anticonvulsant from phenytoin to valproate].
    Niwa K; Kitagawa Y; Yoshii F; Shinohara Y
    Rinsho Shinkeigaku; 1996 Mar; 36(3):492-4. PubMed ID: 8741357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid.
    Korkmazer N; Vurucu S; Demirkaya E; Unay B; Kul M; Akin R; Gokcay E
    Brain Dev; 2006 Sep; 28(8):515-20. PubMed ID: 16682156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of serum albumin, valproic acid and carbamazepine with the pharmacokinetics of phenytoin in cancer patients.
    Joerger M; Huitema AD; Boogerd W; van der Sande JJ; Schellens JH; Beijnen JH
    Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):133-40. PubMed ID: 16918714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.
    Fukuoka N; Uno J; Tsukamoto T; Houchi H; Kimura M; Morita S
    Ther Drug Monit; 2009 Feb; 31(1):57-62. PubMed ID: 19077928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of phenytoin acid and phenytoin sodium with enteral feedings.
    Doak KK; Haas CE; Dunnigan KJ; Reiss RA; Reiser JR; Huntress J; Altavela JL
    Pharmacotherapy; 1998; 18(3):637-45. PubMed ID: 9620116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of steady-state valproate levels by other antiepileptic drugs.
    Sackellares JC; Sato S; Dreifuss FE; Penry JK
    Epilepsia; 1981 Aug; 22(4):437-41. PubMed ID: 6790273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism.
    Nissen-Meyer LS; Svalheim S; Taubøll E; Reppe S; Lekva T; Solberg LB; Melhus G; Reinholt FP; Gjerstad L; Jemtland R
    Epilepsia; 2007 Oct; 48(10):1850-60. PubMed ID: 17634065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic interactions between phenytoin and valproate: individual and combined antiepileptic and neurotoxic actions in mice.
    Chez MG; Bourgeois BF; Pippenger CE; Knowles WD
    Clin Neuropharmacol; 1994 Feb; 17(1):32-7. PubMed ID: 8149357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.